Berardi-HH-in-NSCLC-J-Carcinog-Mutagen-2014

Hedgehog (Hh) Signaling is a Predictor of Clinical Outcome for Advanced Non- Small Cell Lung Cancer (NSCLC)

20 marzo 2014
   

ung cancer still remains the leading cause of cancer deaths in the world and it lacks validated biomarkers to predict clinical outcome. The Hedgehog (Hh) pathway is critical for cell growth and differentiation. The
aim of our study was to evaluate the role of the Hh signaling in the prediction of clinical outcome for advanced
NSCLC.

Leggi di piu

Categorie

Argomenti

AIOM Aloe Ambiente Aspetti Medico-Legali Assistenza Breast Unit Burn Out Crioconservazione Cultura Distress Fertilità Follow-Up Formazione Francesca Morgese Hedgehog Immunotherapy Lung Cancer Marcangolo 7 Marco Pompili Marco Romeo Mariangela Torniai Melanoma Molecular alterations Octreotide oncologia Prevenzione Psico-Oncologia Registro di Mortalità Registro Tumori Ricerca Rossana Berardi Somatostatin Spettacoli Targeted therapy Thymic carcinoma Thymoma Tumori Polmonari Tumori Solidi Vincenzo Catalano Volontariato
©Semper Onlus Via Arco di Augusto 54 Fano (PU) | P.Iva e Codice Fiscale 02451450411 | mail: semperonlus@gmail.com | Credits: StudioYEP